# A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.

> **NCT00625833** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 330 (actual)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** Placebo
- **DRUG:** [S,S]-Reboxetine

## Key facts

- **NCT ID:** NCT00625833
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 330 (ACTUAL)
- **Why stopped:** Study was terminated for futility following the planned interim analysis.
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625833, "A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00625833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*